Conmed (MEX:CNMD) Cyclically Adjusted Revenue per Share: MXN897.09 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:CNMD Conmed Corp MEX:CNMD
80 GF Score
Price MXN720.00
GF Value MXN945.33
! 5 Warning Signs
View Full Analysis

What is Conmed Cyclically Adjusted Revenue per Share?

Conmed MEX:CNMD 80 Cyclically Adjusted Revenue per Share is MXN897.09 as of Jun. 2026. GuruFocus rates MEX:CNMD with a GF Score™ of 80/100 and a GF Value™ of MXN945.33. The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Conmed's adjusted revenue per share for the three months ended in Jun. 2026 was MXN199.008. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is MXN897.09 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Conmed's average Cyclically Adjusted Revenue Growth Rate was 5.70% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 4.80% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 5.40% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 4.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Conmed was 26.30% per year. The lowest was 1.70% per year. And the median was 4.80% per year.

As of today (2026-08-21), Conmed's current stock price is MXN720.00. Conmed's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was MXN897.09. Conmed's Cyclically Adjusted PS Ratio of today is 0.80.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Conmed was 4.95. The lowest was 0.81. And the median was 2.44.


Conmed  (MEX:CNMD) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Conmed's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=720.00/897.09
=0.80

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Conmed was 4.95. The lowest was 0.81. And the median was 2.44.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Conmed Cyclically Adjusted Revenue per Share Related Terms


Conmed Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Conmed's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Conmed Cyclically Adjusted Revenue per Share Chart

Conmed Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 621.51 627.57 613.63 793.71 792.56

Conmed Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,076.82 1,208.83 792.56 817.33 897.09

MEX:CNMD vs ATEC, AORT, IRMD: Cyclically Adjusted Revenue per Share Comparison

For the Medical Devices subindustry, Conmed's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Conmed Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Conmed's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Conmed's Cyclically Adjusted PS Ratio falls into.


MEX:CNMD
80GF Score
Conmed Corp MEX:CNMD
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Conmed Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Conmed's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=199.008/333.9520*333.9520
=199.008

Current CPI (Jun. 2026) = 333.9520.

Conmed Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 127.832 241.428 176.822
201612 150.182 241.432 207.734
201703 126.058 243.801 172.671
201706 126.648 244.955 172.662
201709 122.423 246.819 165.641
201712 154.382 246.524 209.132
201803 128.479 249.554 171.930
201806 144.970 251.989 192.124
201809 130.093 252.439 172.100
201812 164.468 251.233 218.619
201903 145.901 254.202 191.674
201906 156.007 256.143 203.398
201909 154.791 256.759 201.328
201912 166.968 256.974 216.984
202003 168.920 258.115 218.551
202006 127.602 257.797 165.297
202009 178.550 260.280 229.088
202012 155.854 260.474 199.819
202103 151.576 264.877 191.104
202106 156.457 271.696 192.307
202109 159.176 274.310 193.785
202112 171.327 278.802 205.217
202203 137.249 287.504 159.422
202206 187.288 296.311 211.080
202209 177.906 296.808 200.170
202212 160.442 296.797 180.527
202303 170.677 301.836 188.837
202306 171.278 305.109 187.469
202309 167.421 307.789 181.652
202312 176.216 306.746 191.845
202403 165.725 312.332 177.197
202406 195.591 314.175 207.903
202409 200.435 315.301 212.291
202412 231.574 315.605 245.036
202503 210.983 319.799 220.320
202506 207.577 322.561 214.907
202509 199.645 324.800 205.270
202512 215.644 324.054 222.231
202603 186.708 330.213 188.822
202606 199.008 333.952 199.008

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of MXN897.09 mean?
Conmed (MEX:CNMD) has a Cyclically Adjusted Revenue per Share of MXN897.09 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Conmed and its competitors.
Is Conmed's Cyclically Adjusted Revenue per Share too high?
Conmed's current Cyclically Adjusted Revenue per Share is MXN897.09. Overall, Conmed has a GF Score™ of 80/100, reflecting its overall financial health beyond just this single metric.
How does Conmed's Cyclically Adjusted Revenue per Share compare to ATEC and AORT?
Conmed's Cyclically Adjusted Revenue per Share of MXN897.09 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Conmed and its competitors. Conmed's current Cyclically Adjusted Revenue per Share is MXN897.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Conmed stock overvalued right now?
Conmed (MEX:CNMD) has a current Cyclically Adjusted Revenue per Share of MXN897.09. The stock's GF Value™ is MXN945.33, compared to a current price of MXN720.00 — trading 23.8% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is MXN897.09. Conmed's overall GF Score™ is 80/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Conmed (MEX:CNMD), the current Cyclically Adjusted Revenue per Share is MXN897.09 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Conmed (MEX:CNMD) Overvalued in 2026?

Based on GuruFocus' analysis, Conmed stock appears to be undervalued. The current stock price of MXN720.00 is trading 23.8% below its estimated GF Value™ of MXN945.33.

Key valuation signals for MEX:CNMD:

  • Cyclically Adjusted Revenue per Share: MXN897.09
  • GF Value™: MXN945.33 vs. price of MXN720.00 (23.8% below fair value)
  • GF Score™: 80/100 with 5 warning signs

No single metric tells the full story. See the MEX:CNMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Conmed Business Description

Other Exchanges CNMD:USA
Address 11311 Concept Boulevard, Largo, FL, USA, 33773
Conmed Corp is a medical technology company that provides devices and equipment for surgical procedures. The company's products are used by surgeons and other healthcare professionals across specialties, including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. Geographically, the company operates in the United States, Europe, the Middle East & Africa, Asia Pacific, and the Americas, excluding the United States. The majority of revenue is generated from the United States.
80GF Score

Get the complete analysis for MEX:CNMD

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN720.00
Price
MXN945.33
GF Value